Free Trial

Sinovac Vaccine

CHILE

Chilean authorities have announced they remain confident in a vaccine developed by China's Sinovac despite jitters elsewhere after researchers in Brazil acknowledged that its efficacy was lower than initially suggested.


Chile's health regulator was assessing all the available data and would announce its decision on an emergency roll-out for the inoculation soon. Concentrating on the impact on severe symptoms, they believe it should be very effective. The Chilean trade undersecretary, Rodrigo Yanez, spoke to Reuters in an interview.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.